HYPOGLYCAEMIA UNAWARENESS IN DIABETICS TRANSFERRED FROM BEEF/ PORCINE INSULIN TO HUMAN INSULIN

The Lancet

Volumn 330, Issue 8555, 1987, Pages 382-385

  Teuscher, A ^a   Berger, W G ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BOVINE INSULIN; HUMAN INSULIN; PIG INSULIN;

CASE REPORT; DRUG COMPARISON; DRUG SAFETY; DRUG THERAPY; ENDOCRINE SYSTEM; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; JUVENILE DIABETES MELLITUS; PRIORITY JOURNAL; QUESTIONNAIRE; THERAPY; WARNING SIGNAL;

ADOLESCENT; ADULT; AGED; ANIMAL; BLOOD GLUCOSE; CASE REPORT; CATTLE; COMPARATIVE STUDY; DIABETES MELLITUS, INSULIN-DEPENDENT; FOLLOW-UP STUDIES; HUMAN; HYPOGLYCEMIA; INSULIN; INSULIN COMA; MALE; MIDDLE AGE; SWINE; SYMPATHETIC NERVOUS SYSTEM;

EID: 0023238706     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(87)92394-4     Document Type: Article

References (18)

1. Advertisement (Humulin)
2. Comparison of porcine insulin and human insulin (Novo) using the glucose-controlled insulin infusion system, glucose-insulin dose-response curves, and the outpatient effectiveness of human insulin (Novo) in insulin-dependent diabetes
3. Evaluation of efficacy and safety of human insulin (Novo) in the treatment of insulin-dependent diabetes mellitus: a double-blind multicenter clinical trial
4. The efficacy and safety of human insulin (Novo) in insulin-dependent diabetic patients
5. Aenderungen der Hypoglykamie-Fruhsymptome bei Wechsel von tierischem Insulin auf Humaninsulin
6. Diabetes mellitus. Report of a WHO-study group
7. Biosynthetic human insulin in the treatment of diabetes. A double-blind cross-over trial in established diabetic patients
8. Reduced awareness of hypoglycemia after changing from porcine to human insulin in IDDM
9. Substantial rise of plasma β-endorphin levels after insulin-induced hypoglycaemia in human subjects
10. β-endorphin and adrenocorticotropin are secreted concomitantly by the anterior gland
11. Counter-regulatory hormone release after human and porcine insulin in healthy subjects and patients with pituitary disorders
12. Different counterregulatory response to human insulin (recombinant DNA) and purified pork insulin
13. Comparison of the activity and pharmakokinetics of porcine insulin and human insulin (Novo) as assessed by the glucose clamp technique in normal and diabetic man